Capital Markets team supports AIM quoted Eden Research plc on its successful fundraise of up to £11 million

2 minute read
03 August 2023

Our capital markets team has advised AIM quoted biopesticides product and technology company, Eden Research, in relation to its secondary capital fundraising of up to £11 million through a firm placing, conditional placing, subscription and retail offer, with Cenkos Securities plc acting as bookrunner and broker.

Eden Research is an Oxfordshire-based company focused on developing sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries. Eden Research is currently the only UK-quoted company focused on biopesticides for sustainable agriculture and is well positioned to capitalise on the rapidly growing biopesticides market, which is projected to be worth over £11 billion by 2027.

Principal associate in Gowling WLG's capital markets team, Alex Davidson, led on the fundraising, supported by corporate partner David Brennan, legal director Sue Johnston and trainee Nimmi Joseph.

Commenting on the fundraise, Alex Davidson said:

"We are delighted to have assisted Eden Research in completing such a successful fundraise, especially in such a challenging market. We look forward to seeing Eden Research build on its existing success."

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.